MTOR and ovarian cancer: In ovarian cancer cell lines, E2 has been found to stimulate telomerase activity via two mechanisms – transcriptional regulation of hTERT via an ERE-dependent mechanism and the PI3K/Akt/mTOR cascade as well as post-translational regulation through Akt-dependent phosphorylation of hTERT [15].